A detailed history of Canada Pension Plan Investment Board transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 4,900 shares of PCRX stock, worth $84,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,900
Holding current value
$84,475
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.5 - $31.51 $124,950 - $154,399
4,900 New
4,900 $140,000
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $13.8 Million - $18.3 Million
-232,700 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$50.47 - $66.26 $11.7 Million - $15.4 Million
232,700 New
232,700 $13.9 Million
Q1 2020

May 13, 2020

SELL
$28.4 - $50.7 $25,560 - $45,630
-900 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $32,679 - $42,147
900 New
900 $41,000
Q3 2019

Nov 12, 2019

SELL
$35.66 - $44.99 $6.59 Million - $8.32 Million
-184,847 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$36.57 - $47.97 $5.83 Million - $7.65 Million
-159,523 Reduced 46.32%
184,847 $8.04 Million
Q1 2019

May 15, 2019

BUY
$36.47 - $42.17 $6.53 Million - $7.56 Million
179,170 Added 108.46%
344,370 $13.1 Million
Q4 2018

Feb 06, 2019

SELL
$41.31 - $52.16 $2.8 Million - $3.54 Million
-67,786 Reduced 29.09%
165,200 $7.11 Million
Q3 2018

Nov 09, 2018

BUY
$32.85 - $52.0 $157,680 - $249,600
4,800 Added 2.1%
232,986 $11.5 Million
Q2 2018

Aug 07, 2018

BUY
$27.5 - $39.8 $1.31 Million - $1.89 Million
47,600 Added 26.36%
228,186 $7.31 Million
Q1 2018

May 14, 2018

BUY
$29.98 - $46.35 $4.66 Million - $7.2 Million
155,286 Added 613.78%
180,586 $5.63 Million
Q4 2017

Feb 14, 2018

BUY
$31.85 - $46.95 $805,805 - $1.19 Million
25,300
25,300 $1.16 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $790M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.